Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 4/20 | 0.48 |
| ▸ | GSK3B | P49841 | 4/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.44 |
| ▸ | MGLL | Q99685 | 10/20 | 0.42 |
| ▸ | FAAH | O00519 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.42 |
| ▸ | THPO | P40225 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | XBP1 | P17861 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1103799 | 0.79 | GSK3A (0.52) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| Hydrochloric Acid SCHEMBL28991159 | 0.78 | PTGS1 (0.50) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| SCHEMBL25701886 | 0.76 | GSK3A (0.48) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| Ethylene Glycol SCHEMBL28669577 | 0.74 | PTGS1 (0.47) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| SCHEMBL13323652 | 0.74 | GSK3A (0.52) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| SCHEMBL17933659 | 0.73 | GSK3A (0.45) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| SCHEMBL11955666 | 0.73 | GSK3A (0.55) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| SCHEMBL8010430 | 0.73 | GSK3A (0.50) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| SCHEMBL7165261 | 0.73 | GSK3A (0.50) | GSK3AGSK3BPTGS1PTGS2MGLL | |
| SCHEMBL28353956 | 0.73 | GSK3A (0.50) | GSK3AGSK3BPTGS1PTGS2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153581-B2 | Process for producing an injectable medicament preparation | KTB TUMORFORSCHUNGS GMBH (DE) | 2012-04-10 | — | — | US | disclosed |
| US-20100215574-A1 | PROCESS FOR PRODUCING AN INJECTABLE MEDICAMENT PREPARATION | Vergell Medical S.A. (CH) | 2010-08-26 | — | — | US | disclosed |
| US-7445764-B1 | Carrier-drug conjugate | KTB TUMORFORSCHUNGSGESELLSSCHAFT MBH (DE) | 2008-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215574-A1 | PROCESS FOR PRODUCING AN INJECTABLE MEDICAMENT PREPARATION | MMP1, MMP2, DNPEP | GSK3A 4830/4885GSK3B 4846/4885PTGS1 959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.